For patients, the promise of health insurance is simple: pay your premiums, get your care. A recent KFF Health News investigation reveals a very different reality. Insurers routinely deny doctor-recommended treatments, families drain retirement accounts to fill the gap, and reform pledges collect dust while patients fight for their lives.

Sheldon Ekirch spent two years battling Anthem to cover blood plasma infusions for a condition that made her limbs feel as though they were on fire. Each infusion costs roughly $10,000. Her family paid about $90,000 out of pocket before an external review finally overturned the denial. Anthem called it a “favorable response.” Ekirch called it what it was: a company that had no intention of paying until forced.

She is not alone. Payton Herres, a heart transplant recipient, nearly ran out of anti-rejection medication she had taken for over a decade after Anthem denied coverage. Anna Hocum’s insurer repeatedly denied treatment for a rare genetic condition destroying her lung function — forcing her family to crowdfund more than $30,000 while she fought to survive. 

The system producing these outcomes is not broken. It works exactly as designed. Last June, insurers pledged to simplify prior authorization. By February, half who signed the pledge failed to provide any specifics about what had actually changed. The American Medical Association noted that insurers made nearly identical promises in 2018 and delivered little. A patient advocacy CEO put it plainly: the insurer’s fiduciary responsibility runs to Wall Street, not the patient.

What insurers call utilization management, injured patients call obstruction. When a denial delays necessary treatment, the harm does not stay administrative — it becomes medical, and sometimes irreversible. Meaningful reform will require more than pledges. It will require confronting a system that profits from saying no.